Photosensitization refers to light-induced adverse tissue effects resulting from exposure to photoreactive chemicals in combination with ultraviolet (UV) or visible light. Unlike phototoxicity, photoallergy is an immune-mediated delayed hypersensitivity reaction in which light transforms a chemical into a sensitizer capable of activating dendritic cells and inducing allergic contact dermatitis. To support the development of new approach methodologies (NAMs) for photoallergy assessment, this study optimized the human Cell Line Activation Test (h-CLAT) for use with UVA exposure.
The photo-h-CLAT was established by incorporating UVA irradiation (1.7 ± 0.2 mW/cm²; total dose 5 J/cm²) into the standard h-CLAT framework (OECD TG 442E) using THP-1 cells. Four sequential method iterations were evaluated to optimize assay performance and reproducibility. Modifications included changes to pre- and post-exposure incubation periods, rinsing procedures, antibody incubation time, and preparation of test chemicals in either DPBS or phenol red–free medium. Chlorpromazine hydrochloride (CPZ) was tested at multiple concentrations to monitor assay sensitivity and consistency. Following treatment, cells were stained for CD54 and CD86 expression and analyzed by flow cytometry. Compounds were classified as positive when the light-to-dark relative fluorescence intensity ratio was ≥2.0 for CD54 or ≥1.5 for CD86.
CPZ consistently exceeded the CD54 threshold under UVA exposure and was established as a reliable positive control. Following optimization, the photo-h-CLAT correctly identified 9 of 10 reference chemicals with compelling evidence of photoallergenicity. These findings highlight the potential of the photo-h-CLAT as a NAM for identifying photoallergens and support its further refinement and evaluation.